|
Issue # 4, May 8, 2022
- From our desk
- MEDA's Q1 2022 investments
- Portfolio company news
- MEDA around the country
- Spotlight on members
- Upcoming events
|
|
|
|
Thoughts on healthcare investing...
The healthcare industry has convulsed from the COVID pandemic, affected further by systemic inflation, labor shortages and payment capitation. With continued physician, nursing and other healthcare staffing shortages, there is an increasing need for automation to allow the human parts of healthcare delivery to focus on human-critical jobs. Therefore, investments in healthcare AI and process automation continue to grow on a per annum basis with the goal of improving disease prevention, treatment accuracy and effectiveness as well as care efficiency. Telemedicine, digital health and remote patient monitoring have been validated during COVID - but the long term work at optimizing these healthcare tools is still a work in progress.
Picking the winners from the losers will be as challenging as the dot.com era - but there will certainly be winners. 20% of the US GDP was healthcare-related in 2021; the winners will benefit from the value they unlock in their individual domains. Understanding each disease and care process space are essential at making educated investments into the teams with the best grasp of the problem and best shot at entrepreneurial success.
MEDA Angels is a healthcare angel investor group founded by PhDs and MDs. comprised of MDs, PhDs, JDs and financiers that have had aggregate decades of experience in clinical and benchtop science, the finance, legal and regulatory domains of healthcare, offering a deep, 360 degree understanding of the healthcare investment space.
|
|
|
MEDA's Q1 2022 investments
- Trusty.care: SaaS solution for health insurance companies & brokers that optimally matches customers with plans and helps reduce costly customer disenrollment.
- Biotia Inc.: diagnostics using high-throughput next generation sequencing & AI to identify and help target infectious disease viruses & other agents.
- Bendit Technologies: our 3rd investment in this company with an on-demand, bendable microcatheter that can navigate tortuous vasculature to reach targets during neurologic, peripheral & cardiac interventional procedures.
|
|
|
Portfolio company news!
Medical Devices
- Bendit Technologies received FDA 510K approval for their Bendit 21 microcatheter.
- FemSelect was granted its own reimbursement code by CMS for its minimally invasive device to address female pelvic prolapse.
- Landsdowne Labs, an MIT-spin out from the Bob Langer laboratory, executed a partnership with a major metal mining company in Latin America. The company is developing a child-proof coating around coin batteries to prevent ingestion hazards among children.
Digital Health/SaaS
- SeamlessMD recently added the 33-hospital Intermountain Healthcare system to their list of 48 customers! Watch multicare execs discuss how SeamlessMD's patient engagement technology was rolled out across an 11-hospital system, has been fully integrated into Epic & MyChart, and been resulting in measurable reductions in hospital length of stays & readmissions.
- Trusty.care, with multiple health insurance & brokerage customers, has now partnered with MemoryWell to increase Medicare Advantage enrollee satisfaction to diminish member churn and bridge gaps in health care by combining health risk assessment & social determinants of health data. Raising a Series A.
- DynamiCare Health received FDA Breakthrough Device designation for its digital therapeutic intended to treat tobacco use disorder complicating pregnancy and childbirth, part of its larger substance abuse contingency management program.
Consumer goods & healthcare product
- Kinnos has now rolled out their disinfectant product in the large NJ-based Hackensack University Medical Center system, adding to their customer list that includes the Veterans Administration, Orlando Health and others. Published a peer-reviewed paper with Hackensack showing 70% improvement in disinfection quality at hospitals. Raising a Series B.
|
|
|
MEDA around the country
Spring brought many opportunities for deal scouting, broadening networks and meeting startups! Here's what we have been up to:
|
|
- Michael McDonald, JD, a recently retired M&A/private equity lawyer based in London, now spends his time hosting The Wild Golf Podcast! perfects his skills as a long drive competitor (seniors division) & on the side, is an executive coach for women in law, business, sports and the charity sectors.
- Tomas Philipson, PhD, writes regularly for Forbes, WSJ and other leading financial news outlets on macroeconomic topics, including healthcare economics. Here's one he recently authored on out-of-pocket drug costs. Dr. Philipson served as former Acting Chairman of the White House Council of Economic Advisers & is currently the Co-Director of the Center for Choice & Competition, Dept of Economics, Univ of Chicago.
- Matthew Rees is the Founder of Food and Health Facts newsletter as well as the Global Society for Walking Talking (GSWAT). He has also written, with Dr. Lloyd Minor, Dean of Stanford’s School of Medicine, Discovering Precision Health: Predict, Prevent, and Cure to Advance Health and Well-Being.
|
|
Upcoming events!
One more pitch session before summer break!
Wed June 1,
4 - 6 pm PST / 7 - 9 pm EST, Virtual
Limited guest passes.
Startups & Accredited Investors: contact us if interested in attending!
****************
Member social! mid-June 2022
Washington, DC area
details coming
******************
MEDA FUND I
launching Fall 2022
contact us to remain posted
|
|
|
|
|
